VS
First Trust AlphaDEX U.S. Health Care Sector Index ETF (FHH) and CI Global Healthcare Leaders Index ETF (CHCL.B) offer distinct profiles for Canadian ETF investors. A direct comparison shows that FHH focuses its top 3 sector exposures on Healthcare, while CHCL.B leans towards Healthcare, Consumer Non-Cyclicals, and Consumer Cyclicals. When evaluating costs, FHH features a management fee (MER) of 0.7%, compared to 0.35% for CHCL.B. Performance-wise, FHH has returned 20.1% year-to-date with -$2 M in net flows, whereas CHCL.B is at 12.98% with +$38 M. Use the comparison tool below to benchmark these funds across top 10 holdings, yield, sector weights and historical returns.
NAV Performance and Flows
Key Data
Compare
FHH
CHCL.B
| AuM | $5.03 M | $138.73 M |
| Management Fees | 0.70% | 0.35% |
| Exp. ratio | 0.76% | 0.37% |
| Tracking Difference | -1.08% | - |
Historical performance and flows
As of October 19, 2026
| 1M | 3M | YTD | 1Y | 3Y | ||
|---|---|---|---|---|---|---|
| Perf. | FHH | +1.88% | +9.11% | +20.10% | +18.05% | +45.41% |
CHCL.B | +3.33% | +7.91% | +12.98% | +17.28% | +40.46% | |
| Flows | FHH | +$0 M | +$0 M | -$2 M | -$4 M | -$8 M |
CHCL.B | -$3 M | -$3 M | +$38 M | +$37 M | -$33 M |
FHH vs CHCL.B exposure
Countries
FHH
USA
93.13%
CHCL.B
USA
72.62%
Switzerland
8.69%
Other
18.69%
Sectors
FHH
Healthcare
98.23%
CHCL.B
Healthcare
97.45%
As of October 19, 2026
Top 10 Holdings
FHH
Regeneron Pharmaceuticals, Inc.
2.86%
Pfizer Inc.
2.56%
Natera, Inc.
2.55%
Solventum Corp.
2.55%
Zimmer Biomet Holdings, Inc.
2.49%
Universal Health Services, Inc.
2.48%
Boston Scientific Corp.
2.43%
Guardant Health, Inc.
2.37%
Tenet Healthcare Corp.
2.29%
Halozyme Therapeutics, Inc.
2.22%
CHCL.B
Eli Lilly & Co.
10.84%
Johnson & Johnson
7.15%
AbbVie, Inc.
5.04%
Merck & Co., Inc.
4.06%
UnitedHealth Group, Inc.
3.92%
Roche Holding AG
3.41%
Novartis AG
3.07%
AstraZeneca PLC
2.72%
Amgen, Inc.
2.58%
Thermo Fisher Scientific, Inc.
2.55%
Diversification
FHH
Total weight of top 10 holdings out of 72 total
24.80%
CHCL.B
Total weight of top 10 holdings out of 151 total
45.35%
Characteristics
Compare
FHH
CHCL.B
| Provider | First Trust | CI |
| Management | Passively managed | Passively managed |
| Benchmark | StrataQuant Health Care CAD Total Return Index - CAD | Solactive Developed Markets Healthcare 150 CAD Index (CA NTR) - CAD |
| Replication Method | Direct (Physical) | Direct (Physical) |
| Asset Class | Equity | Equity |
| Dividend Policy | Distributing | Distributing |
| Trailing 12m distribution yield | 0.48% | 1.04% |
| Meets ESG criteria | No | No |
| Inception Date | October 30, 2014 | August 17, 2021 |
Frequently asked questions about FHH and CHCL.B
Which ETF has performed better year to date: FHH or CHCL.B?
As of October 19, 2026, FHH has returned 20.10% year to date, while CHCL.B has returned 12.98%. FHH is ahead on YTD performance.
Which ETF is larger by assets under management: FHH or CHCL.B?
As of October 19, 2026, FHH manages $5.03 M in assets, while CHCL.B manages $138.73 M. CHCL.B is the larger fund by AUM.
How are FHH and CHCL.B managed?
FHH is passively managed by First Trust. It tracks the StrataQuant Health Care CAD Total Return Index - CAD benchmark. CHCL.B is passively managed by CI. It tracks the Solactive Developed Markets Healthcare 150 CAD Index (CA NTR) - CAD benchmark.
What sectors do FHH and CHCL.B emphasize?
FHH is most exposed to Healthcare. CHCL.B is most exposed to Healthcare, Consumer Non-Cyclicals, and Consumer Cyclicals.
Which ETF is attracting more investor flows: FHH or CHCL.B?
Year to date, FHH has seen -$2.10 M in net flows, compared with +$37.84 M for CHCL.B. CHCL.B has attracted more net investor money so far.
How do the fees of FHH and CHCL.B compare?
FHH has an expense ratio of 0.76%, while CHCL.B has an expense ratio of 0.37%.
What are the top holdings of FHH and CHCL.B?
FHH's largest holdings include Regeneron Pharmaceuticals, Inc., Pfizer Inc., and Natera, Inc.. CHCL.B's top holdings include Eli Lilly & Co., Johnson & Johnson, and AbbVie, Inc..
Which ETF is more diversified: FHH or CHCL.B?
FHH holds 72 securities, while CHCL.B holds 149. On holdings count, CHCL.B is the more diversified portfolio.
Recent articles about FHH and CHCL.B
The ETF Market Canada is brought to you by Cboe in partnership with Trackinsight SA who is providing all the data, analysis and editorial content on this site. Unless explicitly stated as such, any information that you receive is not real-time.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.